116 related articles for article (PubMed ID: 21901595)
1. Characterization of kinase inhibitors using reverse phase protein arrays.
Martiny-Baron G; Haasen D; D'Dorazio D; Voshol J; Fabbro D
Methods Mol Biol; 2011; 785():79-107. PubMed ID: 21901595
[TBL] [Abstract][Full Text] [Related]
2. Tracing pathway activities with kinase inhibitors and reverse phase protein arrays.
van Oostrum J; Calonder C; Rechsteiner D; Ehrat M; Mestan J; Fabbro D; Voshol H
Proteomics Clin Appl; 2009 Apr; 3(4):412-22. PubMed ID: 21136968
[TBL] [Abstract][Full Text] [Related]
3. Monitoring phosphoproteomic response to targeted kinase inhibitors using reverse-phase protein microarrays.
Lavezzari G; Lackner MR
Methods Mol Biol; 2012; 795():203-15. PubMed ID: 21960225
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of phosphoproteins using microspot immunoassays.
Henjes F; Götschel F; Jöcker A; Korf U
Methods Mol Biol; 2011; 785():191-201. PubMed ID: 21901601
[TBL] [Abstract][Full Text] [Related]
5. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
6. Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
Voshol H; Ehrat M; Traenkle J; Bertrand E; van Oostrum J
FEBS J; 2009 Dec; 276(23):6871-9. PubMed ID: 19860827
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated signal amplification for reverse phase protein array-based protein quantification.
Brase JC; Mannsperger H; Sültmann H; Korf U
Methods Mol Biol; 2011; 785():55-64. PubMed ID: 21901593
[TBL] [Abstract][Full Text] [Related]
8. Utilization of RNAi to validate antibodies for reverse phase protein arrays.
Mannsperger H; Uhlmann S; Korf U; Sahin O
Methods Mol Biol; 2011; 785():45-54. PubMed ID: 21901592
[TBL] [Abstract][Full Text] [Related]
9. Addressing the effects of Salmonella internalization in host cell signaling on a reverse-phase protein array.
Molero C; Rodríguez-Escudero I; Alemán A; Rotger R; Molina M; Cid VJ
Proteomics; 2009 Jul; 9(14):3652-65. PubMed ID: 19609973
[TBL] [Abstract][Full Text] [Related]
10. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
11. Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer.
Pirnia F; Pawlak M; Thallinger GG; Gierke B; Templin MF; Kappeler A; Betticher DC; Gloor B; Borner MM
Proteomics; 2009 Jul; 9(13):3535-48. PubMed ID: 19609961
[TBL] [Abstract][Full Text] [Related]
12. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
[TBL] [Abstract][Full Text] [Related]
13. Protein microarray-based screening of antibody specificity.
Bangham R; Michaud GA; Schweitzer B; Predki PF
Methods Mol Med; 2005; 114():173-82. PubMed ID: 16156103
[TBL] [Abstract][Full Text] [Related]
14. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
16. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
17. Recombinant antibodies for the generation of antibody arrays.
Borrebaeck CA; Wingren C
Methods Mol Biol; 2011; 785():247-62. PubMed ID: 21901605
[TBL] [Abstract][Full Text] [Related]
18. Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays.
Geho D; Lahar N; Gurnani P; Huebschman M; Herrmann P; Espina V; Shi A; Wulfkuhle J; Garner H; Petricoin E; Liotta LA; Rosenblatt KP
Bioconjug Chem; 2005; 16(3):559-66. PubMed ID: 15898722
[TBL] [Abstract][Full Text] [Related]
19. Antibody arrays--an emerging tool in cancer proteomics.
Kopf E; Zharhary D
Int J Biochem Cell Biol; 2007; 39(7-8):1305-17. PubMed ID: 17600752
[TBL] [Abstract][Full Text] [Related]
20. Antibody microarrays as tools for biomarker discovery.
Sanchez-Carbayo M
Methods Mol Biol; 2011; 785():159-82. PubMed ID: 21901599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
